Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Ventum Cap Mkts decreased their FY2025 earnings per share estimates for Cresco Labs in a report released on Wednesday, November 5th. Ventum Cap Mkts analyst A. Semple now forecasts that the company will post earnings of ($0.13) per share for the year, down from their prior forecast of ($0.12). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Ventum Cap Mkts also issued estimates for Cresco Labs’ FY2026 earnings at ($0.10) EPS.
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last announced its quarterly earnings data on Friday, November 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Cresco Labs had a negative return on equity of 13.92% and a negative net margin of 7.79%.The company had revenue of $165.00 million during the quarter, compared to analyst estimates of $163.74 million.
View Our Latest Stock Report on Cresco Labs
Cresco Labs Price Performance
OTCMKTS:CRLBF opened at $1.07 on Monday. The company has a debt-to-equity ratio of 1.33, a current ratio of 3.10 and a quick ratio of 2.22. Cresco Labs has a one year low of $0.43 and a one year high of $1.62. The company has a fifty day moving average price of $1.21 and a 200 day moving average price of $0.90. The stock has a market cap of $380.85 million, a P/E ratio of -7.13 and a beta of 1.51.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Recommended Stories
- Five stocks we like better than Cresco Labs
- What is the Euro STOXX 50 Index?
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- What Are Earnings Reports?
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Using the MarketBeat Dividend Tax Calculator
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
